- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alembic Pharmaceuticals Ltd (ALEM)
Alembic Pharmaceuticals Ltd stock price live, this page displays NSE ALEM stock exchange data. View the ALEM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Alembic Pharmaceuticals Ltd real time stock price chart below.
What Is the Alembic Pharmaceuticals Ltd Stock Price Today?
The Alembic Pharmaceuticals Ltd stock price today is 805.05.
What Is the Stock Symbol for Alembic Pharmaceuticals Ltd?
The stock symbol for Alembic Pharmaceuticals Ltd is "ALEM."
What Stock Exchange Does Alembic Pharmaceuticals Ltd Trade On?
Alembic Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Alembic Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Alembic Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALEM quote. (ISIN: INE901L01018)
What Is the Alembic Pharmaceuticals Ltd Stock Price Today?
The Alembic Pharmaceuticals Ltd stock price today is 805.05.
What Is the Stock Symbol for Alembic Pharmaceuticals Ltd?
The stock symbol for Alembic Pharmaceuticals Ltd is "ALEM."
What Stock Exchange Does Alembic Pharmaceuticals Ltd Trade On?
Alembic Pharmaceuticals Ltd is listed and trades on the NSE stock exchange.
Is Alembic Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Alembic Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALEM quote. (ISIN: INE901L01018)
805.05
+8.00(+1.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
792.55
815.05
52 wk Range
635.80
1,002.00
Earnings results expected tomorrow
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
792.55815.05
52 wk Range
635.801,002.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.51%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.51%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ALEM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
918.20
Upside
+14.06%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell
Analyst Ratings
6 Buy
3 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 918.20
(+14.06% Upside)
Earnings
Latest Release
May 15, 2026
EPS / Forecast
11.40 / 8.90
Revenue / Forecast
18.48B / 19.07B
Compare ALEM to Peers and Sector
Metrics to compare | ALEM | Peers Peers - average of corresponding metrics from companies closely matching ALEM: ZYDUSLIFE, GLENMARK, SUNPHARMA, AUROPHARMA, ALKEM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALEMPeersSector |
|---|---|---|---|---|
P/E Ratio | 23.2x | 29.8x | −0.4x | |
PEG Ratio | 1.50 | 0.78 | 0.00 | |
Price/Book | 2.8x | 4.1x | 2.6x | |
Price / LTM Sales | 2.1x | 4.2x | 3.0x | |
Upside (Analyst Target) | 13.3% | 5.1% | 56.0% | |
Fair Value Upside | Unlock | 3.5% | 9.1% | Unlock |
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Alembic Pharmaceuticals Ltd (ALEM) Stock Price Today?
The Alembic Pharmaceuticals Ltd stock price today is 805.05 INR.
What Stock Exchange Does Alembic Pharmaceuticals Ltd Trade On?
Alembic Pharmaceuticals Ltd is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Alembic Pharmaceuticals Ltd?
The stock symbol for Alembic Pharmaceuticals Ltd is "ALEM."
Does Alembic Pharmaceuticals Ltd Pay Dividends? What’s The Current Dividend Yield?
The Alembic Pharmaceuticals Ltd dividend yield is 1.51%.
What Is the Alembic Pharmaceuticals Ltd Market Cap?
As of today, Alembic Pharmaceuticals Ltd market cap is 157.53B INR.
What Is Alembic Pharmaceuticals Ltd's Earnings Per Share (TTM)?
The Alembic Pharmaceuticals Ltd EPS (TTM) is 34.33.
When Is the Next Alembic Pharmaceuticals Ltd Earnings Date?
Alembic Pharmaceuticals Ltd will release its next earnings report on Aug 04, 2026.
From a Technical Analysis Perspective, Is ALEM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Alembic Pharmaceuticals Ltd Stock Split?
Alembic Pharmaceuticals Ltd has split 0 times.
How Many Employees Does Alembic Pharmaceuticals Ltd Have?
Alembic Pharmaceuticals Ltd has 17244 employees.
What is the current trading status of Alembic Pharmaceuticals Ltd (ALEM)?
As of Aug 03, 2026, Alembic Pharmaceuticals Ltd (ALEM) is trading at a price of 805.05 INR, with a previous close of 797.05 INR. The stock has fluctuated within a day range of 792.55 INR to 815.05 INR, while its 52-week range spans from 635.80 INR to 1,002.00 INR.
What Is Alembic Pharmaceuticals Ltd (ALEM) Price Target According to Analysts?
The average 12-month price target for Alembic Pharmaceuticals Ltd is 918.20 INR, with a high estimate of 1132 INR and a low estimate of 750 INR. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +14.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.